...
首页> 外文期刊>Trials >A randomised controlled trial comparing palate surgery at 6?months versus 12?months of age (the TOPS trial): a statistical analysis plan
【24h】

A randomised controlled trial comparing palate surgery at 6?months versus 12?months of age (the TOPS trial): a statistical analysis plan

机译:随机对照试验将腭手术与6?几个月(The Tops Instics)(The The The The The The The):统计分析计划进行比较

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Cleft palate is among the most common birth abnormalities. The success of primary surgery in the early months of life is crucial for successful feeding, hearing, dental development, and facial growth. Over recent decades, age at palatal surgery in infancy has reduced. The Timing Of Primary Surgery for cleft palate (TOPS) trial aims to determine whether, in infants with cleft palate, it is better to perform primary surgery at age 6 or 12?months (corrected for gestational age). Methods/design The TOPS trial is an international, two-arm, parallel group, randomised controlled trial. The primary outcome is insufficient velopharyngeal function at 5?years of age. Secondary outcomes, measured at 12?months, 3?years, and 5?years of age, include measures of?speech development, safety of the procedure, hearing level, middle ear function, dentofacial development, and growth. The analysis approaches for primary and secondary outcomes are described here, as are the descriptive statistics which will be reported. The TOPS protocol has been published previously. Discussion This paper provides details of the planned statistical analyses for the TOPS trial and will reduce the risk of outcome reporting bias and data-driven results. Trial registration ClinicalTrials.gov NCT00993551 . Registered on 9 October 2009.
机译:背景腭裂是最常见的出生异常之一。初级手术在生命初期的成功对于成功喂养,听力,牙科发展和面部增长至关重要。近几十年来,婴儿期腭手术的年龄降低。腭裂腭裂(上衣)试验的初级手术的时间旨在确定在患有腭裂的婴儿中,最好在6或12岁时进行初级手术(纠正孕龄)。方法/设计顶部试验是国际,双臂,并行组,随机对照试验。主要结果在5年龄的5岁时velopharyngeal函数不足。二次结果,在12?几个月,3年,5岁,包括?语音开发,程序安全,听力水平,中耳功能,牙齿发展和增长的措施。这里描述了初级和二次结果的分析方法,也是将报告的描述性统计数据。顶级协议先前已发布。讨论本文介绍了全体审判计划统计分析的详细信息,并将降低成果报告偏见和数据驱动结果的风险。试验登记ClinicalTrials.gov NCT00993551。 2009年10月9日注册。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号